Digital pathology (DP) is an image-based platform for managing, analysing, and interpreting digital data on a digitised slide. Digital pathology is used in a variety of fields, including forensic pathology, oral pathology, and human pathology. In the not-too-distant future, digital pathology is poised to expedite diagnostic laboratories' and pathologists' workflows and operations.Microarrays and the incorporation of a wide range of predictive models, including hybrid models and API methods, are projected to drive demand for digital image analysis. Computer-aided diagnosis, which combines image processing, physics, mathematics, and computing algorithms, aids in disease identification and evaluation of anatomic structures of interest, as well as disease progression quantification and risk assessment. In the foreseeable future, these advantages are projected to stimulate demand for digital pathology systems. This digital pathology market report details recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, and a competitive landscape.
Request for a sample report: https://whipsmartmi.com/sample/he0774/Digital-Pathology-Market
Key Driving Factors: Telepathology and Virtual Pathology are gaining traction in the global digital pathology market.
In the last few years, the adoption of virtualization technologies has exploded in the IT and operations sectors. Telepathology and virtual pathology are the future frontiers in diagnostic pathology, as pathology is seen as a visual science. In the digital pathology sector, recent advancements in communications, microelectronics, sensor manufacture, and data analysis techniques have provided new opportunities for telepathology and virtual pathology.
Opportunities: Affordable scanners for private pathology practises are being introduced.
For companies in the digital pathology market, the introduction of cheap scanners is projected to provide potential prospects. The majority of private medical offices are modest enterprises that can't afford to invest in costly digital pathology systems. The availability of low-cost scanners will encourage pathologists with limited financial resources to use them.
This report offers the major market player’s profiles, such as Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan),Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada), Sectra AB (Sweden), OptraSCAN (India), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (China), Inspirata, Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), Kanteron Systems (Spain).
Based on Application: In 2021, the university research segment dominated the digital pathology market, accounting for 44.2 percent of total revenue. This expansion is due to the systems' widespread use in various research techniques such as biomarker profiling and tumour morphology analysis. Because of the rising prevalence of chronic diseases, the disease diagnosis sector is predicted to grow at the quickest rate of 6.8% throughout the projection period. Furthermore, manufacturers' focus on the development of unique and speedy diagnostic techniques. Digital technologies make it easier to transfer information between departments and improve each step of the diagnostic process.
The Digital Pathology Market report has been categorized as below
Training & Education
Pharmaceutical & Biotechnology Companies
Hospitals and Reference Laboratories
Academic & Research Institutes
Rest of World
Published Date : September-2021